Impact of alogliptin on lipopolysaccharide-induced experimental Parkinson's disease: Unrevealing neurochemical and histopathological alterations in rodents.

MLA

Dhureja, Maanvi, and Rahul Deshmukh. “Impact of Alogliptin on Lipopolysaccharide-Induced Experimental Parkinson’s Disease: Unrevealing Neurochemical and Histopathological Alterations in Rodents.” European Journal of Pharmacology, vol. 975, July 2024, p. 176635. EBSCOhost, https://doi.org/10.1016/j.ejphar.2024.176635.

APA

Dhureja, M., & Deshmukh, R. (2024). Impact of alogliptin on lipopolysaccharide-induced experimental Parkinson’s disease: Unrevealing neurochemical and histopathological alterations in rodents. European Journal of Pharmacology, 975, 176635. https://doi.org/10.1016/j.ejphar.2024.176635

Chicago

Dhureja, Maanvi, and Rahul Deshmukh. 2024. “Impact of Alogliptin on Lipopolysaccharide-Induced Experimental Parkinson’s Disease: Unrevealing Neurochemical and Histopathological Alterations in Rodents.” European Journal of Pharmacology 975 (July): 176635. doi:10.1016/j.ejphar.2024.176635.